Zanetti G - Search Results

1

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.

Jaccard C, Troillet N, Harbarth S, Zanetti G, Aymon D, Schneider R, Chiolero R, Ricou B, Romand J, Huber O, Ambrosetti P, Praz G, Lew D, Bille J, Glauser MP, Cometta A. Jaccard C, et al. Among authors: zanetti g. Antimicrob Agents Chemother. 1998 Nov;42(11):2966-72. doi: 10.1128/AAC.42.11.2966. Antimicrob Agents Chemother. 1998. PMID: 9797234 Free PMC article. Clinical Trial.

2

Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.

Zanetti G, Heumann D, Gérain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP, Baumgartner JD. Zanetti G, et al. J Immunol. 1992 Mar 15;148(6):1890-7. J Immunol. 1992. PMID: 1541827

3

Septic shock: pathogenesis.

Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Glauser MP, et al. Among authors: zanetti g. Lancet. 1991 Sep 21;338(8769):732-6. doi: 10.1016/0140-6736(91)91452-z. Lancet. 1991. PMID: 1679876 Review. No abstract available.

4

Use of immunoglobulins in prevention and treatment of infection in critically ill patients: review and critique.

Zanetti G, Glauser MP, Baumgartner J. Zanetti G, et al. Rev Infect Dis. 1991 Sep-Oct;13(5):985-92. doi: 10.1093/clinids/13.5.985. Rev Infect Dis. 1991. PMID: 1962115 Review.

5

[Candida fungemia].

Zanetti G, Calandra T, de Muralt B, Bille J, Glauser MP. Zanetti G, et al. Schweiz Med Wochenschr. 1989 Sep 9;119(36):1213-8. Schweiz Med Wochenschr. 1989. PMID: 2678447 French.

6

Anti-endotoxin antibodies and other inhibitors of endotoxin.

Zanetti G, Glauser MP, Baumgartner JD. Zanetti G, et al. New Horiz. 1993 Feb;1(1):110-9. New Horiz. 1993. PMID: 7922383 Review.

7

Sepsis and septic shock.

Zanetti G, Baumgartner JD, Glauser MP. Zanetti G, et al. Schweiz Med Wochenschr. 1997 Mar 22;127(12):489-99. Schweiz Med Wochenschr. 1997. PMID: 9106949 Review.

8

Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.

Heumann D, Le Roy D, Zanetti G, Eugster HP, Ryffel B, Hahne M, Tschopp J, Glauser MP. Heumann D, et al. Among authors: zanetti g. J Inflamm. 1995-1996;47(4):173-9. J Inflamm. 1995. PMID: 9144074

9

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.

Zanetti G, Harbarth SJ, Trampuz A, Ganeo M, Mosimann F, Chautemps R, Morel P, Lew D, Zimmerli W, Lange J, Glauser M. Zanetti G, et al. Int J Antimicrob Agents. 1999 Feb;11(2):107-13. doi: 10.1016/s0924-8579(98)00104-6. Int J Antimicrob Agents. 1999. PMID: 10221413 Clinical Trial.

10

CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.

de Werra I, Zanetti G, Jaccard C, Chioléro R, Schaller MD, Yersin B, Glauser MP, Calandra T, Heumann D. de Werra I, et al. Among authors: zanetti g. Swiss Med Wkly. 2001 Jan 27;131(3-4):35-40. doi: 10.4414/smw.2001.05883. Swiss Med Wkly. 2001. PMID: 11219189 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

814 results

Search Page

Filters